Lieferant: MP Biomedicals

ICNA0215692690EA 564 EUR
ICNA0215692690 ICNA0215692625 ICNA0215692680

Tobramycin is an aminoglycoside antibiotic derived from Streptomyces tenebrarius and used to treat various types of bacteria infections, particularly Gram-negative infections. It is especially effective against species of Pseudomonas. It works by binding to a site on bacterial 30S and 50S ribosome, preventing formation of the 70S complex. As a result, mRNA cannot be translated into protein and cell death ensues. Tobramycin is preferred over gentamicin for Pseudomonas aeruginosa pneumonia due to better lung penetration.

Tobramycin is used in the treatment of superficial infections of the eye, such as bacterial conjunctivitis. Tobramycin is also indicated for gram-negative infections like meningitis in neonates, brucellosis, pelvic inflammatory disease, Yersinia pestis infection (plague). Its used as an antimicrobial.

Mode of action: Binds to 70S ribosomal subunit, inhibits translocation, and hence elicits miscoding.
Spectrum of activity: Gram negative bacteria.

Soluble in water (50 mg/ml).

Formel: C₁₈H₃₇N₅O₉
Molecular Weight: 467,51 g/mol
MDL: MFCD00077885
CAS-Nummer: 32986-56-4


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR